Share Twitter LinkedIn Facebook Email Karen Reckamp, MD, MS Medical Director, Clinical Research Operations shares Stage III Lung Cancer Receptible vs. Unreceptible at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www.moasc.org for more information Advertisement
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read
FDA Approves Inotuzumab Ozogamicin (BESPONSA) for Acute Lymphoblastic Leukemia in Pediatric Patients [Exclusive Video] Acute Lymphoblastic Leukemia 3 Mins Read
Spotlight on CAR T-cell Therapy in 2024: Advances & Clinical Insights Acute Lymphoblastic Leukemia 3 Mins Read